Overview

  • Product name
  • Description
    Goat polyclonal to TPD52L2
  • Tested applications
    Suitable for: WB, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Cynomolgus monkey, Orangutan
  • Immunogen

    Synthetic peptide:

    SGDKPLSDPAP

    with a Cysteine residue linker, corresponding to C terminal amino acids 195-205 of Human TPD52L2 (NP_003279.2).

  • Positive control
    • Human brain cortex, spleen and tonsil tissues; Human breast cancer lysate.

Properties

Applications

Our Abpromise guarantee covers the use of ab113952 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 22 kDa.
ELISA 1/16000.
IHC-P Use a concentration of 3.75 µg/ml.

Target

Images

  • ab113952, at 3.75 µg/ml, staining TPD52L2 in Formalin-Fixed, Paraffin-Embedded Human brain cortex tissue by Immunohistochemistry.
  • ab113952, at 3.75 µg/ml, staining TPD52L2 in Formalin-Fixed, Paraffin-Embedded Human spleen tissue by Immunohistochemistry.
  • ab113952, at 3.75 µg/ml, staining TPD52L2 in Formalin-Fixed, Paraffin-Embedded Human tonsil tissue by Immunohistochemistry.
  • Anti-TPD52L2 antibody (ab113952) at 0.1 µg/ml + Human breast cancer lysate (in RIPA buffer) at 35 µg
    Developed using the ECL technique

    Predicted band size : 22 kDa

References

ab113952 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab113952.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up